Next Article in Journal
Revisiting the Rate-Limiting Step of the ANS–Protein Binding at the Protein Surface and Inside the Hydrophobic Cavity
Next Article in Special Issue
Tiliacora triandra (Colebr.) Diels Leaf Aqueous Extract Inhibits Hepatic Glucose Production in HepG2 Cells and Type 2 Diabetic Rats
Previous Article in Journal
Design, Synthesis, Molecular Docking, and Tumor Resistance Reversal Activity Evaluation of Matrine Derivative with Thiophene Structure
Previous Article in Special Issue
Inhibitory Effect of Thai Purple Rice Husk Extract on Chemically Induced Carcinogenesis in Rats
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Four Novel Phenanthrene Derivatives with α-Glucosidase Inhibitory Activity from Gastrochilus bellinus

by
Htoo Tint San
1,2,
Nutputsorn Chatsumpun
3,
Thaweesak Juengwatanatrakul
4,
Natapol Pornputtapong
5,
Kittisak Likhitwitayawuid
1 and
Boonchoo Sritularak
1,6,*
1
Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand
2
Department of Pharmacognosy, University of Pharmacy, Yangon 11031, Myanmar
3
Department of Pharmacognosy, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand
4
Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Ubon Ratchathani 34190, Thailand
5
Department of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand
6
Natural Products for Ageing and Chronic Diseases Research Unit, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand
*
Author to whom correspondence should be addressed.
Molecules 2021, 26(2), 418; https://doi.org/10.3390/molecules26020418
Submission received: 24 December 2020 / Revised: 3 January 2021 / Accepted: 12 January 2021 / Published: 14 January 2021
(This article belongs to the Special Issue Natural Products in Asia)

Abstract

:
Four new phenanthrene derivatives, gastrobellinols A-D (1–4), were isolated from the methanolic extract of Gastrochilus bellinus (Rchb.f.) Kuntze, along with eleven known phenolic compounds including agrostophyllin (5), agrostophyllidin (6), coniferyl aldehyde (7), 4-hydroxybenzaldehyde (8), agrostophyllone (9), gigantol (10), 4-(methoxylmethyl)phenol (11), syringaldehyde (12), 1-(4′-hydroxybenzyl)-imbricartin (13), 6-methoxycoelonin (14), and imbricatin (15). Their structures were determined by spectroscopic methods. Each isolate was evaluated for α-glucosidase inhibitory activity. Compounds 1, 2, 3, 7, 9, 13, and 15 showed higher activity than the drug acarbose. Gastrobellinol C (3) exhibited the strongest α-glucosidase inhibition with an IC50 value of 45.92 μM. A kinetic study of 3 showed competitive inhibition on the α-glucosidase enzyme. This is the first report on the phytochemical constituents and α-glucosidase inhibitory activity of G. bellinus.

1. Introduction

Diabetes mellitus (DM), one of the most common metabolic diseases, is characterized by high blood glucose levels due to a deficiency of insulin in the body or insufficient insulin sensitivity [1]. α-Glucosidase inhibitors (AGIs), for example, acarbose and voglibose, are the drugs of choice for treating type II DM patients owing to their minimal side effects. However, these AGI drugs still have shortcomings, involving the high cost of production and the need for sugar-like unit(s) in their core structure, and this has motivated researchers to find alternative sources of AGIs [2]. Recently, several plant secondary metabolites of different classes have been investigated as potential candidates for AGI drug development. Interestingly, a great number of phytochemicals obtained from the Orchidaceae family have been found to possess strong α-glucosidase inhibitory activity [3,4,5]. Orchidaceae is one of the largest families in the plant kingdom and consists of about 735 genera and more than 20,000 species [6]. Many have been widely used as principal components in traditional Chinese medicine (TCM) and thus have been extensively investigated and found to be a rich source of unusual secondary metabolites [7]. Gastrochilus, a small genus of monopodial herbs in Orchidaceae, comprises approximately 62 species, mainly found in Southeast Asia [8]. Gastrochilus bellinus (Rchb.f.) Kuntze (“Suea Dam” in Thai and “Wat-Won-Thit-Khwa” in Myanmar) has stems enclosed in basal sheaths of leaves. Its sub-umbellate inflorescence contains small flowers (2–3 cm in diameter), which are distinct morphological features of this genus. The key characteristics of G. bellinus are flowers having pale yellow sepals, petals with brownish–purple markings, and a central cushion on white lip epichile with a groove or cavity at the base (Figure 1) [9]. Prior to this study, there were no records on the phytochemical and biological investigation of this plant. As part of our continuing studies on bioactive compounds from orchids [10,11,12], we investigated the chemical constituents of G. bellinus and their α-glucosidase inhibitory potential. In this study, a dried MeOH extract prepared from G. bellinus was suspended in water and partitioned with EtOAc and butanol to give EtOAc, butanol, and aqueous extracts, which were then evaluated for their α-glucosidase inhibitory effect. The EtOAc extract exhibited the strongest activity with 80% inhibition at a concentration of 100 μg/mL and, therefore, was selected for further study. The butanol and aqueous extracts were found to be devoid of activity (less than 10% inhibition).

2. Results and Discussion

2.1. Structural Characterization

This study led to the isolation of four hitherto unknown compounds (14) (Supplementary Materials), and eleven known compounds, including agrostophyllin (5), agrostophyllidin (6), coniferyl aldehyde (7), 4-hydroxybenzaldehyde (8), agrostophyllone (9), gigantol (10), 4-(methoxylmethyl)phenol (11), syringaldehyde (12), 1-(4′-hydroxybenzyl)-imbricartin (13), 6-methoxycoelonin (14), and imbricatin (15) (Figure 2).
Compound 1 was obtained as a brown amorphous solid. The high-resolution APCI (Atmospheric-pressure chemical ionization) mass spectrum showed a protonated molecular ion [M + H]+ at m/z 377.1360 (calculated for C23H21O5 377.1389), suggesting the molecular formula C23H20O5. The IR spectrum displayed bands at 3360, 2921, 1659, and 1633 cm−1, indicative of aromatic and hydroxyl functional groups. The UV spectrum of compound 1 showed maximal absorptions at 206 and 284 nm. The 1H NMR spectrum (Table 1) suggested a dihydrophenanthropyran structure by the presence of signals for two pairs of methylene protons at δ 2.72 (4H, br s, H2-9, H2-10), a two-proton singlet at δ 5.17 (2H, s, H2-11), and two aromatic proton singlets at δ 6.40 (1H, s, H-1) and 6.69 (1H, s, H-8) [13]. In addition, a resonance for a methoxy group was observed at δ 3.79 (3H, s, 6-OMe). The NMR assignment of H-1 was deduced from its HMBC correlations with C-3 (δ 114.5), C-10 (δ 27.6), and C-4a (δ 111.8). The assignment of H-8 was based on its HMBC correlations with C-6 (δ 141.7), C-9 (δ 27.1), and C-4b (119.6). Apart from the aforementioned signals, the 1H NMR spectrum presented resonances for a pair of methylene protons at 3.88 (2H, s, H2-α′), and two pairs of two-proton doublets at δ 7.15 (2H, d, J = 8.7 Hz, H-2′, H-6′) and 6.66 (2H, d, J = 8.7 Hz, H-3′, H-5′), which are characteristic signals of a p-hydroxybenzyl group. This was supported by the HMBC correlations of C-α′ (δ 27.6) with H-2′/H-6′ (Figure 3). The 13C NMR spectrum (Table 2) showed 21 carbon signals representing 23 carbon atoms. The location of the methoxyl group at C-6 was confirmed by its NOESY interaction with H2-11 (Figure 3). In the HMBC spectrum, 3-bond correlations from H2-α′ (δ 3.88) to C-4 (δ 150.8), C-2 (δ 154.8) and C-2′/6′ (δ 129.4) connected the 9,10-dihydrophenanthropyran nucleus with the p-hydroxybenzyl skeleton at C-3. Based on the above NMR data, compound 1 was determined as a new dihydrophenanthropyran derivative (Figure 2) and given the trivial name gastrobellinol A. The chemical structure of this compound was similar to that of 1-(4′-hydroxybenzyl)-imbricartin (13) [14], except that in 1, the p-hydroxybenzyl moiety was located at C-3, instead of C-1, as in 13. It was observed that C-1 (δ 108.0) of compound 1 resonated at a more downfield position (6.9 ppm) than C-3 (δ 101.1) of 13 when measured in the same NMR solvent (acetone-d6). The upfield shift of C-3 in 13 was due to the two ortho-oxygenations at C-2 and C-4. Moreover, the singlet proton of H-1 of 1 showed HMBC correlation with C-10, whereas no analogous HMBC correlation was observed for H-3 in 13.
Compound 2 was isolated as a brown amorphous solid. The high-resolution APCI mass spectrum showed a protonated molecular ion [M + H]+ at m/z 389.1351 (calculated for C24H21O5 389.1389), suggesting the molecular formula C24H20O5. The UV spectrum of compound 2 (MeOH) showed maximum absorptions at 205, 225, 270, and 380 nm, which were similar to those of a phenanthopyran derivative [15]. The IR spectrum displayed strong absorption bands at 3360, 2921, 1658, and 1633 cm−1. The 1H NMR spectrum (Table 1) exhibited aromatic protons with ortho-coupling at δ 7.55 (1H, d, J = 9.3 Hz, H-9) and 7.78 (1H, d, J = 9.3 Hz, H-10), and aromatic protons at δ 6.91 (1H, s, H-3) and 7.25 (1H, s, H-8). A pair of oxymethylene protons appeared at δ 5.64 (2H, s, H2-11), indicating the presence of a phenanthropyran structure. Moreover, resonances for two methoxy groups were observed at δ 3.94 (3H, s, 2-OMe) and 3.93 (3H, s, 6-OMe). Additional signals for a pair of methylene protons at 4.29 (2H, s, H2-α׳) and two pairs of two-proton doublets at δ 7.01 (2H, d, J = 8.4 Hz, H-2′, H-6′) and 6.66 (2H, d, J = 8.4 Hz, H-3′, H-5′) suggested the presence of a p-hydroxybenzyl moiety, which should be located at C-1, as evidenced by the 3-bond coupling between H-2′/H-6′ and C-α′ (δ 28.9). The HMBC connectivities from H2-α′ (δ 4.29) to C-2 (δ 156.2), C-10a (δ 129.5), and C-2′/6′ (δ 129.0) supported the position of the p-hydroxybenzyl moiety at C-1. In support of this, NOESY correlations (Figure 3) were found from H2-α′ (δ 4.29) to H-2′/H6′ and H-10. The methoxy groups were placed at C-2 and C-6 from the NOESY cross-peaks between H-3 (δ 6.91) and 2-OMe protons, and between H2-11 (δ 5.64) and 6-OMe protons (δ 3.93). Based on the above NMR data, compound 2 was characterized as a new phenanthropyran derivative possessing a p-hydroxybenzyl moiety at C-1 (Figure 2) and named gastrobellinol B.
Compound 3 was collected as a brown amorphous solid. The high-resolution APCI mass spectrum showed a protonated molecular ion [M + H]+ at m/z 375.1214 (calculated for C23H19O5 375.1232), suggesting the molecular formula C23H18O5. The UV maximal absorptions at 225, 270, 365, and 380 nm of compound 3 were similar to those of 2, suggesting the same basic skeleton. The IR spectrum displayed strong absorption bands at 3354, 2925, 1652, and 1614 cm−1. The 1H and 13C NMR (Table 1 and Table 2) and DEPT spectra of compound 3 exhibited signals similar to those of 2, except that compound 3 had only one methoxy group that showed a cross-peak at δ 3.92 (3H, s, 6-OMe)/δ 60.4 in the HSQC spectrum. The position of the methoxy group at C-6 was deduced from its NOESY cross-peak with H2-11 (2H, δ 5.60, s). In the HMBC spectrum (Figure 3), H2-11 (δ 5.60) showed a 3-bond correlation with C-6 (δ 143.2), which was also correlated to the 6-OMe protons. The HMBC correlation from H2-α′ (2H, δ 4.31, s) to C-2 (δ 153.7), C-10a (δ 129.9), and C-2′/C-6′ (δ 129.1) confirmed the linkage point between the phenanthropyran and the p-hydroxybenzyl unit. Based on the aforementioned NMR data, compound 3 was determined to be a de-2-O-methyl derivative of 2 (Figure 2) and given the trivial name gastrobellinol C.
Compound 4 was purified as a brown amorphous solid. The high-resolution APCI mass spectrum showed a protonated molecular ion [M + H]+ at m/z 363.1211 (calculated for C22H19O5 363.1232), suggesting the molecular formula C22H18O5. The UV spectrum of compound 4 showed maximal absorptions at 230, 265, 355, and 370 nm, suggesting a phenanthrene core structure [16]. The IR spectrum displayed absorption bands at 3360 cm−1 for OH, and 2921 and 1658 cm−1 for aromatic rings. The 1H-NMR spectrum (Table 1) exhibited proton signals similar to those of compound 3. However, in compound 4, the signal for the oxymethylene protons of the pyran ring was absent and replaced by a highly deshielded aromatic proton at δ 9.12 (1H, s, H-5). This suggested that compound 4 was a phenanthrene, having a p-hydroxybenzyl unit attached to C-1, similar to compound 3. This was confirmed by the presence of signals for aromatic protons of H-9 (1H, δ 7.48, d, J = 9.0 Hz) and H-10 (1H, δ 7.64, d, J = 9.0 Hz), and p-hydroxybenzyl protons of H-2′/H-6′ (2H, δ 7.03, d, J = 8.4 Hz), H-3′/H-5′ (2H, δ 6.66, d, J = 8.4 Hz), and H2-α′ (δ 4.34). The 13C NMR (Table 2) and DEPT spectra showed only one signal for a methylene carbon at (δ 29.4), which was correlated to the methylene protons at 4.34 (2H, s, H2-α׳) in the HSQC spectrum. The HMBC spectrum (Figure 3) displayed 3-bond correlations from H-5 (δ 9.12) to C-7 (δ 144.0) and C-8a (δ 126.4), and from H2-α′ (δ 4.34) to C-2 (δ 152.4), C-10a (δ 133.3), and C-2′/C-6′ (δ 129.0), confirming the proposed phenanthrene-benzyl skeleton. In the NOESY spectrum (Figure 3), the methoxyl protons at δ 4.06 (3H, s, 4-OMe) displayed a cross-peak with the proton at δ 6.94 (1H, s, H-3). A NOESY correlation (Figure 3) from H2-α′ (δ 4.34) with H-10 (1H, δ 7.64, d, J = 9.0 Hz) and H-2′/H-6′ was also observed. From all the NMR and MS data, it was concluded that compound 4 was a new phenanthrene with a p-hydroxybenzyl substituent (Figure 2), and the trivial name gastrobellinol D was given to the compound.
The other phenolic compounds (Figure 2) were identified by comparison of their spectroscopic data with previous reported data as follows: agrostophyllin (5) [15], agrostophyllidin (6) [17], coniferyl aldehyde (7) [18], 4-hydroxybenzaldehyde (8) [19], agrostophyllone (9) [17], gigantol (10) [20], 4-(methoxylmethyl)phenol (11) [21], syringaldehyde (12) [22], 1-(4′-hydroxybenzyl)-imbricartin (13) [14], 6-methoxycoelonin (14) [23], and imbricatin (15) [24].

2.2. α-Glucosidase Inhibitory Activity

Compounds 115 were evaluated for their α-glucosidase inhibitory activity. Gastrobellinol A (1), gastrobellinol B (2), gastrobellinol C (3), and 1-(4′-hydroxybenzyl)-imbricartin (13) showed strong activity with IC50 values of 88.72, 97.78, 45.92, and 53.69 µM, respectively, when compared with the drug acarbose (IC50 447.36 µM) (Table 3). Coniferyl aldehyde (7), agrostophyllone (9), and imbricatin (15) also exhibited appreciable activity with IC50 values of 380.92, 280.98, and 301.12 µM, respectively. It can be noted herein that for derivatives of phenanthrene or dihydrophenanthrene, the presence of a pyran ring or a p-hydroxy benzyl unit is important for α-glucosidase inhibitory activity, as reflected by the low IC50 values of compounds 1, 2, 3, and 13. Structures without a p-hydroxy benzyl group (compounds 9 and 15) or a pyran ring (compound 4) exhibited little or no activity.
Due to its high potency and availability, compound 3 was subjected to a kinetic study to determine the mode of enzyme inhibition. Lineweaver–Burk plots of the inverted values of velocity (1/V) versus the inverted values of substrate concentration (1/[S]) were prepared and analyzed, in comparison with that of acarbose, by varying the concentration (0.25–2.0 mM) of the substrate (pNPG) in the presence or absence of compound 3 at two different concentrations (20 and 40 μM).
The drug acarbose, as expected, showed competitive inhibition, as determined from the Lineweaver–Burk plot (Figure 4a). The secondary plot of acarbose, generated by replotting the slopes of the lines against the inhibitor concentration, gave a Ki value of 143.6 μM (Table 4). The obtained kinetic parameters of compound 3 are listed in Table 4. The maximum velocity (Vmax) value was determined as 0.1 A405/min, and the Michaelis–Menten constant (Km) as 0.8, 0.9, and 1.1 µM (Figure 4b). The presence of compound 3 at different concentrations (20 µM and 40 µM) did not change the Vmax, but the Km of the enzyme was increased. These results suggest that 3 is a competitive inhibitor of this enzyme. A secondary plot of 3 gave a Ki value of 87.3 µM. Several phenolic compounds from plants have been earlier reported as competitive inhibitors of α-glucosidase, for example, dihydrobenzoxanthones from Artocarpus elasticus [25] and flavonoids from Agrimonia pilosa [26].

3. Materials and Methods

3.1. General Experimental Procedures

UV spectroscopic data were determined using an Agilent Cary 60 Spectrophotometer (Penang, PG, Malaysia), and the IR data were obtained via a Perkin–Elmer FT-IR 1760x spectrophotometer (Boston, MA, USA). High-resolution Atmospheric Pressure Chemical Ionization mass spectra (HR-APCI-MS) were recorded with a Bruker micro TOF-QII mass spectrometer (Billerica, MA, USA). 1H and 13C NMR spectra were recorded with a Bruker Avance DPX-300 (Billerica, MA, USA).

3.2. Plant Material

The whole plants of Gastrochilus bellinus were purchased from Chatuchak market, Bangkok, in March 2018. Plant identification was done by one of the authors (B. Sritularak) and compared with the database of the Botanical Garden Organization. A voucher specimen (BS-GBel-032561) has been deposited at the herbarium of the Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University.

3.3. Extraction and Isolation

The air-dried samples of Gastrochilus bellinus (3.6 kg) were chopped and extracted with methanol (MeOH) to obtain a MeOH extract after removal of the solvent. The MeOH extract (750 g) was suspended in water and partitioned with ethyl acetate (EtOAc) and n-butanol (BuOH) to get an EtOAc, a BuOH, and an aqueous extract after drying. The EtOAc extract (60 g) was further fractionated by vacuum–liquid chromatography (VLC) on silica gel (CH2Cl2-EtOAc, gradient up to 4:6, followed by CH2Cl2–acetone, isocratic, 1:1) to give three fractions (A–C). Fraction A (32.2 g) was separated by column chromatography (CC, silica gel CH2Cl2-EtOAc, isocratic, 9.8:0.2) to give eight fractions (AI–AVIII). Fraction AI (560 mg) was separated again by CC (silica gel, CH2Cl2-EtOAc, isocratic, 9.8:0.2) to obtain five fractions (AI1–AI5). Fraction AI3 was subjected to column chromatography (CC, silica gel, hexane–EtOAc, gradient) followed by Sephadex LH-20 (acetone) to yield agrostophyllin (5) (27.2 mg) and agrostophyllidin (6) (4.1 mg). Fraction AI4 was purified on Sephadex LH-20 (acetone) to yield coniferyl aldehyde (7) (5.3 mg). Fraction AI5 was separated on Sephadex LH-20 (acetone) to give AI5a to AI5h. From fraction AI5c, 4-hydroxybenzaldehyde (8) (50.2 mg), Agrostophyllone (9) (7 mg), and compound 1 (2.2 mg) were obtained by purifying on silica gel column (hexane–EtOAc, isocratic, 7:3). Compound 2 (5.2 mg) was isolated from fraction AI5d by purifying on CC (hexane–EtOAc, isocratic, 7:3). Gigantol (10) (20.4 mg), 4-(methoxylmethyl)phenol (11) (73.3 mg), and syringaldehyde (12) (5.6 mg) were collected from fraction AI5f by using reverse phase C-18 CC (MeOH–water, gradient). Fraction AI5h was purified on CC (silica gel, CH2Cl2–EtOAc, isocratic, 9.8:0.2) to afford 1-(4′-hydroxybenzyl)-imbricartin (13) (9.9 mg). Fraction AIII (105.7 mg) was separated on Sephadex LH-20 (acetone) to give four fractions (AIII1 to AIII4). AIII2 was purified on Sephadex LH-20 (MeOH) to get 6-methoxycoelonin (14) (6.9 mg). Compound 3 (10.5 mg) and compound 4 (3.6 mg) were obtained from fraction AIII3 by purifying on CC (silica gel, hexane–acetone, gradient). Imbricatin (15) (57.3 mg) was collected from fraction AV by purifying on Sephadex LH-20 (CH2Cl2–MeOH, 1:1).
Gastrobellinol A (1): Brown amorphous solid; UV (MeOH): λmax (log ε) 206 (4.76), 284 (4.34) nm; IR: νmax 3360, 2921, 2851, 1659 and 1633 cm−1; HR-APCI-MS: [M + H]+ m/z 377.1360 (calculated for C23H21O5 377.1389); 1H and 13C NMR data, see Table 1 and Table 2.
Gastrobellinol B (2): Brown amorphous solid; UV (MeOH): λmax (log ε) 205 (4.37), 225 (4.40), 270 (4.42), 380(3.49) nm; IR: νmax 3360, 2921, 2850, 1658 and 1633 cm−1; HR-APCI-MS: [M + H]+ at m/z 389.1351 (calculated for C24H21O5 389.1389); 1H and 13C NMR data, see Table 1 and Table 2.
Gastrobellinol C (3): Brown amorphous solid; UV (MeOH): λmax (log ε) 225 (4.61), 270 (4.52), 365 (3.62), 380(3.64) nm; IR: νmax 3354, 2925, 2853, 1652 and 1614 cm−1; HR-APCI-MS: [M + H]+ m/z 375.1214 (calculated for C23H19O5 375.1232); 1H and 13C NMR data, see Table 1 and Table 2.
Gastrobellinol D (4): Brown amorphous solid; UV (MeOH): λmax (log ε) 230 (3.79), 265 (3.82), 255 (3.96), and 370 (3.12) nm; IR: νmax 3360, 2921, 2851, 1658, 1632 cm−1; HR-APCI-MS: [M + H]+ m/z 363.1211 (calculated for C22H19O5 363.1232); 1H and 13C NMR data, see Table 1 and Table 2.

3.4. α-Glucosidase Inhibitory Assay

The α-glucosidase enzyme inhibition assay was carried out according to the method in our previous report [27]. The inhibitory activity was determined by measuring the p-nitrophenol, a yellow color substance that can be monitored at 405 nm, released from p-nitrophenyl-α-D-glucopyranoside (pNPG) by the α-glucosidase enzyme. The test samples were initially dissolved in 50% DMSO, and then, 10 µL of the sample solution and 40 µL of 0.1 unit/mL α-glucosidase were incubated at 37 °C for 10 min. After that, to start the reaction, 50 µL of 2 mM pNPG was added to the mixture and incubated at 37 °C for 20 min. One hundred microliters of 1 M Na2CO3 was added to stop the reaction, and then, the absorbance was measured at 405 nm. Acarbose was used as a positive control, and 5% DMSO was used as a negative control. Each experiment was performed in triplicate. Data were displayed as mean ± SD.
The enzyme kinetics parameters (Km and Vmax) were determined by analyzing the double reciprocal Lineweaver–Burk plot (1/V vs. 1/[S]). Each experiment was carried out by varying the concentration of pNPG (2.0, 1.0, 0.5, and 0.25 mM) in the absence and presence of different concentrations of the test sample. The reaction was monitored at 405 nm by a microplate reader every 5 min for a total time of 25 min. Each experiment was performed in triplicate. Acarbose and 5% DMSO served as the positive and negative controls, respectively. A secondary plot for acarbose was generated by plotting the slopes of the double-reciprocal lines versus inhibitor concentration [28]. For compound 3, secondary plots were plots of the inverted values of Km (1/Km) as a function of inhibitor concentration. The inhibition constant (Ki) was then calculated from the intersection point.

4. Conclusions

This study is the first report on the secondary metabolites of Gastrochilus bellinus. In summary, the phytochemical investigation of Gastrochilus bellinus led to the isolation of four new compounds gastrobellinols A-D (1–4), along with eleven known compounds. When isolates were determined for α-glucosidase inhibitory activity, compounds 1, 2, 3, 7, 8, 13, and 15 showed higher α-glucosidase inhibitory activity than acarbose. The potent α-glucosidase inhibitor, compound 3, revealed its competitive inhibition on the α-glucosidase enzyme.

Supplementary Materials

Figure S1: APCI-MS spectrum of compound 1, Figure S2: 1H NMR (acetone-d6, 300 MHz) spectrum of compound 1, Figure S3: 13C NMR and DEPT (acetone-d6, 75 MHz) spectrum of compound 1, Figure S4: HSQC spectrum of compound 1, Figure S5: HMBC spectrum of compound 1, Figure S6: NOESY spectrum of compound 1, Figure S7: APCI-MS spectrum of compound 2, Figure S8: 1H NMR (acetone-d6, 300 MHz) spectrum of compound 2, Figure S9: 13C NMR and DEPT (acetone-d6, 75 MHz) spectrum of compound 2, Figure S10: HSQC spectrum of compound 2, Figure S11: HMBC spectrum of compound 2, Figure S12: NOESY spectrum of compound 2, Figure S13: APCI-MS spectrum of compound 3, Figure S14: 1H NMR (acetone-d6, 300 MHz) spectrum of compound 3, Figure S15: 13C NMR and DEPT (acetone-d6, 75 MHz) spectrum of compound 3, Figure S16: HSQC spectrum of compound 3, Figure S17: HMBC spectrum of compound 3, Figure S18: NOESY spectrum of compound 3, Figure S19: APCI-MS spectrum of compound 4, Figure S20: 1H NMR (acetone-d6, 300 MHz) spectrum of compound 4, Figure S21: 13C NMR and DEPT (acetone-d6, 75 MHz) spectrum of compound 4, Figure S22: HSQC spectrum of compound 4, Figure S23: HMBC spectrum of compound 4, Figure S24: NOESY spectrum of compound 4.

Author Contributions

B.S. conceived, designed, and supervised the research project and prepared and edited the manuscript. H.T.S. performed the experiments and prepared the manuscript. N.C. and N.P. supervised the α-glucosidase inhibition assay. T.J. performed the MS experiments. K.L. provided comments and suggestions on the preparation of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the 90th Anniversary of Chulalongkorn University Fund (Ratchadaphiseksomphot Endowment Fund), batch 46 (2/2020).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data presented in this study are available in the article and in the Supplementary Material.

Acknowledgments

H.T.S. is grateful to the Graduate School, Chulalongkorn University for a CU-ASEAN Ph.D. scholarship.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013, 36 (Suppl. 1), S67. [Google Scholar] [CrossRef] [Green Version]
  2. van de Laar, F.A. Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes. Vasc. Health Risk. Manag. 2008, 4, 1189–1195. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Kumar, S.; Narwal, S.; Kumar, V.; Prakash, O. α-Glucosidase inhibitors from plants: A natural approach to treat diabetes. Pharmacogn. Rev. 2011, 5, 19–29. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. San, H.T.; Boonsnongcheep, P.; Putalun, W.; Mekboonsonglarp, W.; Sritularak, B.; Likhitwitayawuid, K. α-Glucosidase inhibitory and glucose uptake stimulatory effects of phenolic compounds from Dendrobium christyanum. Nat. Prod. Commun. 2020, 15, 1–8. [Google Scholar] [CrossRef] [Green Version]
  5. Inthongkaew, P.; Chatsumpun, N.; Supasuteekul, C.; Kitisripanya, T.; Putalun, W.; Likhitwitayawuid, K.; Sritularak, B. α-Glucosidase and pancreatic lipase inhibitory activities and glucose uptake stimulatory effect of phenolic compounds from Dendrobium formosum. Rev. Bras. Farmacogn. 2017, 27, 480–487. [Google Scholar] [CrossRef]
  6. Willis, J.C. A Dictionary of the Flowering Plants and Ferns; Cambridge University Press: London, UK, 1966. [Google Scholar]
  7. Gutiérrez, R.M.P. Orchids: A review of uses in traditional medicine, its phytochemistry and pharmacology. J. Med. Plants Res. 2010, 4, 592–638. [Google Scholar] [CrossRef]
  8. Liu, Q.; Zhou, S.S.; Li, R.; Tan, Y.H.; Zyaw, M.; Xing, X.K.; Gao, J.Y. Notes on the genus Gastrochilus (Orchidaceae) in Myanmar. PhytoKeys 2020, 138, 113–123. [Google Scholar] [CrossRef]
  9. Chen, S.C.; Tsi, Z.H.; Wood, J.J. Gastrochilus D. Don. In Flora of China (Vol. 25); Wu, Z.Y., Raven, P.H., Hong, D.Y., Eds.; Science Press: Beijing, China; Missouri Botanical Garden Press: St. Louis, MO, USA, 2009; pp. 491–498. [Google Scholar]
  10. Sarakulwattana, C.; Mekboonsonglarp, W.; Likhitwitayawuid, K.; Rojsitthisak, P.; Sritularak, B. New bisbibenzyl and phenanthrene derivatives from Dendrobium scabrilingue and their α-glucosidase inhibitory activity. Nat. Prod. Res. 2020, 34, 1694–1701. [Google Scholar] [CrossRef]
  11. Thant, M.T.; Chatsumpun, N.; Mekboonsonglarp, W.; Sritularak, B.; Likhitwitayawuid, K. New Fluorene derivatives from Dendrobium gibsonii and their α-glucosidase inhibitory activity. Molecules 2020, 25, 4391. [Google Scholar] [CrossRef]
  12. Khoonrit, P.; Mirdogan, A.; Dehlinger, A.; Mekboonsonglarp, W.; Likhitwitayawuid, K.; Priller, J.; Böttcher, C.; Sritularak, B. Immune modulatory effect of a novel 4,5-dihydroxy-3,3′,4′-trimethoxybibenzyl from Dendrobium lindleyi. PLoS ONE 2020, 15, e0238509. [Google Scholar] [CrossRef]
  13. Majumder, P.L.; Sen, S.; Banerjee, S. Agrostophyllol and isoagrostophyllol, two novel diastereomeric 9,10-dihydrophenanthropyran derivatives from the orchid Agrostophyllum callosum. Tetrahedron 1999, 55, 6691–6702. [Google Scholar] [CrossRef]
  14. Dong, F.W.; Fan, W.W.; Xu, F.Q.; Wan, Q.L.; Su, J.; Li, Y.; Zhou, L.; Zhou, J.; Hu, J.M. Inhibitory activities on nitric oxide production of stilbenoids from Pholidota yunnanensis. J. Asian Nat. Prod. Res. 2013, 15, 1256–1264. [Google Scholar] [CrossRef] [PubMed]
  15. Majumder, P.L.; Sabzabadi, E. Agrostophyllin, a naturally occurring phenanthropyran derivative from Agrostophyllum khasiyanum. Phytochemistry 1988, 27, 1899–1901. [Google Scholar] [CrossRef]
  16. Ito, M.; Matsuzaki, K.; Wang, J.; Daikonya, A.; Wang, N.L.; Yao, X.S.; Kitanaka, S. New phenanthrenes and stilbenes from Dendrobium loddigesii. Chem. Pharm. Bull. 2010, 58, 628–633. [Google Scholar] [CrossRef] [Green Version]
  17. Majumder, P.L.; Lahiri, S.; Mukhoti, N. Four stilbenoids from the orchid Agrostophyllum khasiyanum. Phytochemistry 1996, 42, 1157–1161. [Google Scholar] [CrossRef]
  18. Moujir, L.; Seca, A.M.; Silva, A.M.; Barreto, M.C. Cytotoxic activity of diterpenes and extracts of Juniperus brevifolia. Planta Med. 2008, 74, 751–753. [Google Scholar] [CrossRef] [Green Version]
  19. Panyo, J.; Matsunami, K.; Panichayupakaranant, P. Bioassay-guided isolation and evaluation of antimicrobial compounds from Ixora megalophylla against some oral pathogens. Pharm. Biol. 2016, 54, 1522–1527. [Google Scholar] [CrossRef]
  20. Chen, Y.; Xu, J.; Yu, H.; Qing, C.; Zhang, Y.; Wang, L.; Liu, Y.; Wang, J. Cytotoxic phenolics from Bulbophyllum odoratissimum. Food Chem. 2008, 107, 169–173. [Google Scholar] [CrossRef]
  21. Kwon, J.; Hiep, N.T.; Kim, D.W.; Hong, S.; Guo, Y.; Hwang, B.Y.; Lee, H.J.; Mar, W.; Lee, D. Chemical constituents isolated from the root bark of Cudrania tricuspidata and their potential neuroprotective effects. J. Nat. Prod. 2016, 79, 1938–1951. [Google Scholar] [CrossRef]
  22. Shirali, A.; Sriram, M.; Hall, J.J.; Nguyen, B.L.; Guddneppanavar, R.; Hadimani, M.B.; Ackley, J.F.; Siles, R.; Jelinek, C.J.; Arthasery, P.; et al. Development of synthetic methodology suitable for the radiosynthesis of combretastatin A-1 (CA1) and its corresponding prodrug CA1P. J. Nat. Prod. 2009, 72, 414–421. [Google Scholar] [CrossRef]
  23. Majumder, P.L.; Banerjee, S.; Sen, S. Three stilbenoids from the orchid Agrostophyllum callosum. Phytochemistry 1996, 42, 847–852. [Google Scholar] [CrossRef]
  24. Simmler, C.; Antheaume, C.; Lobstein, A. Antioxidant biomarkers from Vanda coerulea stems reduce irradiated HaCaT PGE-2 production as a result of COX-2 inhibition. PLoS ONE 2010, 5, e13713. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Jenis, J.; Baiseitova, A.; Yoon, S.H.; Park, C.; Kim, J.Y.; Li, Z.P.; Lee, K.W.; Park, K.H. Competitive α-glucosidase inhibitors, dihydrobenzoxanthones, from the bark of Artocarpus elasticus. J. Enzym. Inhib. Med. Chem. 2019, 34, 1623–1632. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Park, M.J.; Kang, Y.H. Isolation of isocoumarins and flavonoids as α-glucosidase inhibitors from Agrimonia pilosa L. Molecules 2020, 25, 2572. [Google Scholar] [CrossRef] [PubMed]
  27. San, H.T.; Chaowasku, T.; Mekboonsonglarp, W.; Rodsiri, R.; Sritularak, B.; Buraphaka, H.; Putalun, W.; Likhitwitayawuid, K. Constituents of Huberantha jenkinsii and their biological activities. Molecules 2020, 25, 3533. [Google Scholar] [CrossRef]
  28. Butterworth, P.J. The use of Dixon plots to study enzyme inhibition. Biochim. Biophys. Acta 1972, 289, 251–253. [Google Scholar] [CrossRef]
Sample Availability: Samples of the compounds 115 are available from the authors.
Figure 1. Gastrochilus bellinus (Rchb.f.) Kuntze.
Figure 1. Gastrochilus bellinus (Rchb.f.) Kuntze.
Molecules 26 00418 g001
Figure 2. Chemical structures of compounds 115.
Figure 2. Chemical structures of compounds 115.
Molecules 26 00418 g002
Figure 3. The key HMBC and NOESY correlations of compounds 14.
Figure 3. The key HMBC and NOESY correlations of compounds 14.
Molecules 26 00418 g003
Figure 4. Lineweaver–Burk plots of (a) acarbose and (b) compound 3.
Figure 4. Lineweaver–Burk plots of (a) acarbose and (b) compound 3.
Molecules 26 00418 g004
Table 1. 1H (300 MHz) NMR data of compounds 14 in acetone-d6.
Table 1. 1H (300 MHz) NMR data of compounds 14 in acetone-d6.
Position1234
16.40, s---
2----
3-6.91, s6.79, s6.94, s
4----
4a----
4b----
5---9.12, s
6----
7----
86.69, s7.25, s7.23, s7.21, s
8a----
92.72, br s7.55, d (9.3)7.53, d (9.3)7.48, d (9.0)
102.72, br s7.78, d (9.3)7.75, d (9.3)7.64, d (9.0)
10a----
115.17, s5.64, s5.60, s
α′3.88, s4.29, s4.31, s4.34, s
1′----
2′7.15, d (8.7)7.01, d (8.4)7.07, d (8.4)7.03, d (8.4)
3′6.66, d (8.7)6.66, d (8.4)6.67, d (8.4)6.66, d (8.4)
4′----
5′6.66, d (8.7)6.66, d (8.4)6.67, d (8.4)6.66, d (8.4)
6′7.15, d (8.7)7.01, d (8.4)7.07, d (8.4)7.03, d (8.4)
2-OMe-3.94, s--
4-OMe---4.06, s
6-OMe3.79, s3.93, s3.92, s-
Table 2. 13C (75 MHz) NMR data of compounds 14 in acetone-d6.
Table 2. 13C (75 MHz) NMR data of compounds 14 in acetone-d6.
Position1234
1108.0116.1114.0113.2
2154.8156.2153.7152.4
3114.598.2101.898.7
4150.8151.5151.0157.7
4a111.8112.1111.9114.9
4b119.6118.1118.4125.3
5121.3120.1119.9112.8
6141.7143.3143.2145.2
7148.4149.6149.4144.0
8114.9110.9110.7111.4
8a128.6125.2125.0126.4
927.1125.8125.5127.1
1027.6122.6122.6120.5
10a132.4129.5129.9133.3
1163.363.863.7-
α′27.628.929.0 29.4
1′132.6132.4132.6132.6
2′129.4129.0129.1129.0
3′114.6114.9114.9114.8
4′155.2155.2155.2155.2
5′114.6114.9114.9114.8
6′129.4129.0129.1129.0
2-OMe-55.8--
4-OMe---54.9
6-OMe60.460.460.4-
Table 3. α-Glucosidase inhibitory activity of compounds 115.
Table 3. α-Glucosidase inhibitory activity of compounds 115.
CompoundIC50 (μM)
Gastrobellinol A (1)88.72 ± 4.1
Gastrobellinol B (2)97.78 ± 3.1
Gastrobellinol C (3)45.92 ± 2.8
Gastrobellinol D (4)NA
Agrostophyllin (5) NA
Agrostophyllidin (6) NA
Coniferyl aldehyde (7) 380.92 ± 9.3
4-Hydroxybenzaldehyde (8) NA
Agrostophyllone (9) 280.98 ± 15.9
Gigantol (10) NA
4-(Methoxylmethyl)phenol (11) NA
Syringaldehyde (12) NA
1-(4′-Hydroxybenzyl)-imbricartin (13) 53.69 ± 12.5
6-Methoxycoelonin (14) NA
Imbricatin (15) 301.12 ± 6.6
Acarbose447.36 ± 28.3
NA means no inhibitory activity.
Table 4. Kinetic parameters of α-glucosidase inhibition in the presence of compound 3.
Table 4. Kinetic parameters of α-glucosidase inhibition in the presence of compound 3.
InhibitorDose (µM)Vmax (∆ A405/min)Km (mM)Ki (µM)
None-0.10.8
Compound 3200.10.987.3
400.11.1
Acarbose3870.14.8143.6
7440.16.5
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

San, H.T.; Chatsumpun, N.; Juengwatanatrakul, T.; Pornputtapong, N.; Likhitwitayawuid, K.; Sritularak, B. Four Novel Phenanthrene Derivatives with α-Glucosidase Inhibitory Activity from Gastrochilus bellinus. Molecules 2021, 26, 418. https://doi.org/10.3390/molecules26020418

AMA Style

San HT, Chatsumpun N, Juengwatanatrakul T, Pornputtapong N, Likhitwitayawuid K, Sritularak B. Four Novel Phenanthrene Derivatives with α-Glucosidase Inhibitory Activity from Gastrochilus bellinus. Molecules. 2021; 26(2):418. https://doi.org/10.3390/molecules26020418

Chicago/Turabian Style

San, Htoo Tint, Nutputsorn Chatsumpun, Thaweesak Juengwatanatrakul, Natapol Pornputtapong, Kittisak Likhitwitayawuid, and Boonchoo Sritularak. 2021. "Four Novel Phenanthrene Derivatives with α-Glucosidase Inhibitory Activity from Gastrochilus bellinus" Molecules 26, no. 2: 418. https://doi.org/10.3390/molecules26020418

Article Metrics

Back to TopTop